Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
DOI: 10.1056/NEJM199508313330902 Ferrannini & DeFronzo (2015): Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Published preclinical data in rodents suggests doses equivalent to 200mg+ in humans produce off-target effects on folate metabolism and S-adenosylmethionine (SAMe) pools
32 DaubeufS.LeroyP.PaolicchiA.PompellaA.WellmanM.GalteauM
Maurer L, Mai K, Krude H, Haynes JD, Weygandt M, Spranger J
Hmong Daw
Ning XR, Liu Y, Huang Z, Huang H, Li Q, Li Z, Sheng J, Wu
US$ 21.07
US$ 26.19
US$ 23.96
